ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ReiThera and Exothera Collaborate to Develop Large-scale, Low Cost per Dose Manufacturing Process to Deliver Novel Vaccines to Low- and Middle-Income Countries
April 12, 2022Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation -
ReiThera Announces Preliminary Phase 2 Data from its COVID-19 Vaccine Candidate
July 13, 2021ReiThera Srl today announces the preliminary safety and immunogenicity data from the Phase 2 clinical "COVITAR" trial with GRAd-COV2, its novel COVID-19 vaccine candidate. -
COVID-19 Vaccine Candidate Enters Phase 1 Study with First Healthy Volunteer
August 25, 2020ReiThera has announced the first healthy volunteer has been dosed in a Phase 1 study of the Company's vaccine candidate (GRAd-COV2) against the novel coronavirus (SARS-CoV-2). -
Sabin and ReiThera Enter Clinical Manufacturing Pact
May 15, 2020BARDA provides the Sabin Vaccine Institute with additional $20mn for further development of Ebola Sudan and Marburg vaccines.
Pharma Sources Insight January 2025
